Genesis Therapeutics
Jun Feng currently serves as the Director of Medicinal Chemistry at Genesis Therapeutics since May 2023. Prior to this role, Jun Feng held various positions including Director at Erasca, Inc. from October 2018 to December 2022, and Sr. Scientist at Wellspring Biosciences from September 2012 to September 2018. Jun Feng began a career in medicinal chemistry at Pfizer as a Scientist I from May 1997 to July 2002 before moving to Syrrx, Inc. as a Scientist II from July 2002 to March 2005, and then to Takeda San Diego, Inc. as a Scientist II from March 2005 to March 2012.
This person is not in any offices
Genesis Therapeutics
3 followers
Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D. In addition, Peppi Prasit, Ph.D. leads the Scientific Advisory Board and Leonard Bell, M.D., serves as Chair of the Board of Directors. Its team of technology trailblazers and proven drug developers are driving the discovery and development of novel small molecule drugs to treat patients suffering with severe and debilitating diseases. The company expects to develop drug candidates both internally and selectively in partnership with biopharmaceutical companies.